These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 8833354)

  • 1. In vitro activities of A-gliadin-related synthetic peptides: damaging effect on the atrophic coeliac mucosa and activation of mucosal immune response in the treated coeliac mucosa.
    Maiuri L; Troncone R; Mayer M; Coletta S; Picarelli A; De Vincenzi M; Pavone V; Auricchio S
    Scand J Gastroenterol; 1996 Mar; 31(3):247-53. PubMed ID: 8833354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterizing one of the DQ2 candidate epitopes in coeliac disease: A-gliadin 51-70 toxicity assessed using an organ culture system.
    Martucci S; Fraser JS; Biagi F; Corazza GR; Ciclitira PJ; Ellis HJ
    Eur J Gastroenterol Hepatol; 2003 Dec; 15(12):1293-8. PubMed ID: 14624152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An immunodominant DQ8 restricted gliadin peptide activates small intestinal immune response in in vitro cultured mucosa from HLA-DQ8 positive but not HLA-DQ8 negative coeliac patients.
    Mazzarella G; Maglio M; Paparo F; Nardone G; Stefanile R; Greco L; van de Wal Y; Kooy Y; Koning F; Auricchio S; Troncone R
    Gut; 2003 Jan; 52(1):57-62. PubMed ID: 12477760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gliadin induced changes in the expression of MHC-class II antigens by human small intestinal epithelium. Organ culture studies with coeliac disease mucosa.
    Fais S; Maiuri L; Pallone F; De Vincenzi M; De Ritis G; Troncone R; Auricchio S
    Gut; 1992 Apr; 33(4):472-5. PubMed ID: 1582589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-mediated immunity to gliadin within the small-intestinal mucosa in coeliac disease.
    Ferguson A; MacDonald TT; McClure JP; Holden RJ
    Lancet; 1975 Apr; 1(7912):895-7. PubMed ID: 47539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wheat peptide challenge in coeliac disease.
    Sturgess R; Day P; Ellis HJ; Lundin KE; Gjertsen HA; Kontakou M; Ciclitira PJ
    Lancet; 1994 Mar; 343(8900):758-61. PubMed ID: 7907731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo gluten ingestion in coeliac disease.
    Ciclitira PJ; Ellis HJ
    Dig Dis; 1998; 16(6):337-40. PubMed ID: 10207218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease.
    Maiuri L; Ciacci C; Ricciardelli I; Vacca L; Raia V; Auricchio S; Picard J; Osman M; Quaratino S; Londei M
    Lancet; 2003 Jul; 362(9377):30-7. PubMed ID: 12853196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro (organ culture) studies of the toxicity of specific A-gliadin peptides in celiac disease.
    de Ritis G; Auricchio S; Jones HW; Lew EJ; Bernardin JE; Kasarda DD
    Gastroenterology; 1988 Jan; 94(1):41-9. PubMed ID: 3335296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal mucosa of celiacs in remission is unable to abolish toxicity of gliadin peptides on in vitro developing fetal rat intestine and cultured atrophic celiac mucosa.
    Cornell HJ; Auricchio RS; De Ritis G; De Vincenzi M; Maiuri L; Raia V; Silano V
    Pediatr Res; 1988 Aug; 24(2):233-7. PubMed ID: 3186334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of gliadin peptides B1-B4 in celiac disease. I. Organ culture studies.
    Stallmach A; Belitz HD; Gellermann B; Schäfer H; Wieser H; Stern M
    J Pediatr Gastroenterol Nutr; 1987; 6(3):335-40. PubMed ID: 3430242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secretion of gliadin antibody by coeliac jejunal mucosal biopsies cultured in vitro.
    Ciclitira PJ; Ellis HJ; Wood GM; Howdle PD; Losowsky MS
    Clin Exp Immunol; 1986 Apr; 64(1):119-24. PubMed ID: 3731523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 31-43 amino acid sequence of the alpha-gliadin induces anti-endomysial antibody production during in vitro challenge.
    Picarelli A; Di Tola M; Sabbatella L; Anania MC; Di Cello T; Greco R; Silano M; De Vincenzi M
    Scand J Gastroenterol; 1999 Nov; 34(11):1099-102. PubMed ID: 10582760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A non-toxic analogue of a coeliac-activating gliadin peptide: a basis for immunomodulation?
    Biagi F; Ellis HJ; Parnell ND; Shidrawi RG; Thomas PD; O'Reilly N; Corazza GR; Ciclitira PJ
    Aliment Pharmacol Ther; 1999 Jul; 13(7):945-50. PubMed ID: 10383530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro toxicity of gluten peptides in coeliac disease assessed by organ culture.
    Shidrawi RG; Day P; Przemioslo R; Ellis HJ; Nelufer JM; Ciclitira PJ
    Scand J Gastroenterol; 1995 Aug; 30(8):758-63. PubMed ID: 7481543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissociation between systemic and mucosal humoral immune responses in coeliac disease.
    O'Mahony S; Arranz E; Barton JR; Ferguson A
    Gut; 1991 Jan; 32(1):29-35. PubMed ID: 1991635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocytotic segregation of gliadin peptide 31-49 in enterocytes.
    Zimmer KP; Fischer I; Mothes T; Weissen-Plenz G; Schmitz M; Wieser H; Büning J; Lerch MM; Ciclitira PC; Weber P; Naim HY
    Gut; 2010 Mar; 59(3):300-10. PubMed ID: 19654123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human interleukin 10 suppresses gliadin dependent T cell activation in ex vivo cultured coeliac intestinal mucosa.
    Salvati VM; Mazzarella G; Gianfrani C; Levings MK; Stefanile R; De Giulio B; Iaquinto G; Giardullo N; Auricchio S; Roncarolo MG; Troncone R
    Gut; 2005 Jan; 54(1):46-53. PubMed ID: 15591503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activation of adenylate cyclase of atrophic celiac intestinal mucosa by wheat gliadin-derived peptides.
    Beguinot L; Auricchio S; Bernardin JE; de Ritis G; De Vincenzi M; Kasarda DD; Macchia V; Silano V
    Pediatr Res; 1986 Jan; 20(1):42-4. PubMed ID: 3945514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase.
    Arentz-Hansen H; Körner R; Molberg O; Quarsten H; Vader W; Kooy YM; Lundin KE; Koning F; Roepstorff P; Sollid LM; McAdam SN
    J Exp Med; 2000 Feb; 191(4):603-12. PubMed ID: 10684852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.